Saudi Arabia: Sees War With Houthis Extending Well Into 2027 – RTRS Cites Western Officials
- Aims For Allies To Make Gains On Battlefield In Yemen Before Any Negotiations With Houthis
Pfizer: Enters Exclusive Licensing Agreement With Starna Therapeutics For Autoimmune Diseases
- Obtains Exclusive Rights Outside Greater China For Three Pre-IND In Vivo CAR-T Programmes
- Starna To Receive Upfront Payment Of $330M
- Starna Eligible For Up To $2.30B In Milestone Payments Plus Royalties
- Holds Options To Expand Territory To Include Greater China
$TGT | Target Q3 2026 Earnings
- Net Sales: $27.07B (est $26.53B)
- Adj EPS: $2.65 (est $2.08)
- Gross Margin: 30.5% vs 28.2% Y/Y
- Sees FY Net Sales Growth: Around 6%
- Sees FY Oper Income Margin Rate: Around 6.2%
- Sees FY Adj EPS: $10.65 To $11.40 (prev $9.90 To $10.90)